PA
MMSI icon

PharVision Advisers’s Merit Medical Systems MMSI Stock Holding History

PharVision Advisers’s Portfolio MMSI Stock Details MMSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,467
Closed -$217K – 434
2025
Q4 		$217K Sell
2,467
-722
-23% -$61.4K 0.11% 488
2025
Q3 		$265K Buy
+3,189
New +$278K 0.15% 298

Other funds holding MMSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

PharVision Advisers's MMSI Position: Q1 2026 in Review

PharVision Advisers sold out of Merit Medical Systems (MMSI) in Q1 2026, closing a stake of 2,467 shares — an estimated $217K sold.

PharVision Advisers first reported a position in MMSI in Q3 2025 and held it in 2 quarters. The position peaked at $265K in Q3 2025. 399 funds tracked by Wall St. Rank hold MMSI as of Q1 2026.

  • PharVision Advisers reported no remaining Merit Medical Systems position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 2,467 Merit Medical Systems shares in Q1 2026, an estimated $217K.
  • PharVision Advisers first reported a position in Merit Medical Systems in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Merit Medical Systems position peaked at $265K in Q3 2025.
  • 399 funds tracked by Wall St. Rank held Merit Medical Systems as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.